Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft

Journal of Comparative Neurology

Volumn 426, Issue 1, 2000, Pages 106-116

  Wade, Juli ^a   Buhlman, Lori ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

6 Hydroxydopamine; Double grafts; Fetal grafts; Parkinson's disease; Reinnervation

Indexed keywords

OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FETAL TISSUE TRANSPLANTATION; FETUS; IMMUNOHISTOCHEMISTRY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REINNERVATION; SUBSTANTIA NIGRA;

EID: 0034626625     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9861(20001009)426:1<106::aid-cne7>3.0.co;2-z     Document Type: Article

References (58)

1. Estimation of nuclear population from microtome sections
2. Differential effect of subthalamic nucleus ablation on dopamine D1 and D2 agonist-induced rotation in 6-hydroxydopamine-lesioned rats
3. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
4. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing
5. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different sites
6. Activation of neurotransplants in humans
7. Reduction of apomorphine induced rotational behaviour by subthalamic lesion in 6-OHDA-lesioned rats is associated with a normalization of firing rate and discharge pattern of pars reticulata neurons
8. Dopaminergic mechansims in subthalamic nucleus of rat: Analysis using horseradish peroxidase and microiontophoresis
9. In vivo evidence for a dendritic release of dopamine in cat substantia nigra
10. Dendritic release of dopamine in the substantia nigra
11. Extrastriatal dopaminergic innervation of human basal ganglia
12. Host afferents into intrastriatal transplants of fetal ventral mesencephalon
13. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites
14. Nigrostriatal reconstruction after 6-OHDA lesions in rats: Combination of dopamine-rich nigral grafts and nigrostriatal 'bridge' grafts
15. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
16. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease
17. The role of dopamine released from distal and proximal dendrites of nigrostriatal dopaminergic neurons in the control of GABA transmission in the thalamic nucleus ventralis medialis in the cat
18. Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft
19. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: An electrophysiological and c-fos study
20. Increased subthalamic neuronal activity following nigral dopaminergic lesion independent of disinhibition via the globus pallidus
21. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat
22. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease
23. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus
24. Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat
25. Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus
26. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease
27. Nigral dopaminergic mechanisms in drug-induced circling
28. Role of nigral dopamine in amphetamine-induced locomotor activity
29. Dopamine differentiation factors produce partial motor recovery in 6-hydroxydopamine lesioned rats
30. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
31. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies
32. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
33. Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry
34. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up
35. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
36. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants
37. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
38. Specific outgrowth of ventral mesencephalic grafts to the catecholamine-depleted striatum of adult hosts
39. Neural transplantation in Parkinson's disease
40. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: A tracer study using fluorogold and horseradish peroxidase
41. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: An ultrastructural double-labeling immunocytochemical study
42. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants
43. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations
44. Neural transplantation cannula and microinjector system: Experimental and clinical experience. Technical note
45. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease
46. Intranigral fetal dopamine grains induce behavioural compensation in the rat Parkinson model
47. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: A detailed account of the methodology
48. Fetal nigral transplantation as a therapy for Parkinson's disease
49. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
50. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon
51. Evidence that L-dopa-induced rotational behaviour is dependent on both striatal and nigral mechanisms
52. Dopaminergic grains in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats
53. Dopamine receptor interactions: Some implications for the treatment of Parkinson's disease
54. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
55. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grains in Parkinson's disease
56. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
57. Intranigral transplants of GABA-rich striatal tissue induce behavioural recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants
58. Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behaviour